IL-6 downstream signaling also involves activation of the PI3K/AKT/mammalian target of rapamycin (mTOR) signaling cascade and Villanueva and colleagues observed overactivated mTOR signaling in 50% of human HCC samples [132]. Here, IL6 is linked to hepatocellular carcinoma.